| Autor: |
Olson D; University of Colorado School of Medicine, Aurora, CO, USA.; Colorado School of Public Health, Aurora.; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Calvimontes DM; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; La Comisión Presidencial de Atención a la Emergencia COVID-19 (Coprecovid), Guatemala., Lamb MM; Colorado School of Public Health, Aurora., Guzman G; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Barrios E; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Chacon A; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Rojop N; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Arias K; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Gomez M; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Bolanos GA; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Monzon J; Centers for Disease Control and Prevention, Guatemala City, Guatemala., Chard AN; Centers for Disease Control and Prevention, Atlanta, GA, USA., Iwamoto C; Centers for Disease Control and Prevention, Atlanta, GA, USA., Duca LM; Centers for Disease Control and Prevention, Atlanta, GA, USA., Vuong N; Centers for Disease Control and Prevention, Atlanta, GA, USA., Fineman M; Colorado School of Public Health, Aurora., Lesteberg K; University of Colorado School of Medicine, Aurora, CO, USA., Beckham D; University of Colorado School of Medicine, Aurora, CO, USA., Santiago ML; University of Colorado School of Medicine, Aurora, CO, USA., Quicke K; Colorado State University, Fort Collins, CO., Ebel G; Colorado State University, Fort Collins, CO., Gutierrez EZ; Centers for Disease Control and Prevention, Guatemala City, Guatemala., Azziz-Baumgartner E; Centers for Disease Control and Prevention, Atlanta, GA, USA., Hayden FG; University of Virginia School of Medicine, Charlottesville, VA, USA., Mansour H; University of Colorado - Denver, Denver, CO., Edwards K; Vanderbilt University School of Medicine, Nashville, TN, USA., Newman LS; University of Colorado School of Medicine, Aurora, CO, USA.; Colorado School of Public Health, Aurora., Asturias EJ; University of Colorado School of Medicine, Aurora, CO, USA.; Colorado School of Public Health, Aurora.; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala.; La Comisión Presidencial de Atención a la Emergencia COVID-19 (Coprecovid), Guatemala. |
| Abstrakt: |
We evaluated the clinical and socioeconomic burdens of respiratory disease in a cohort of Guatemalan banana plantation workers. All eligible workers were offered enrollment from June 15-December 30, 2020, and annually, then followed for influenza-like illnesses (ILI) through: 1) self-reporting to study nurses, 2) sentinel surveillance at health posts, and 3) absenteeism. Workers with ILI submitted nasopharyngeal swabs for influenza, RSV, and SARS-CoV-2 testing, then completed surveys at days 0, 7, and 28. Through October 10, 2021, 1,833 workers developed 169 ILIs (12.0/100 person-years) and 43 (25.4%) of these ILIs were laboratory-confirmed SARS-CoV-2 (3.1/100 person-years). Workers with SARS-CoV-2-positive ILI reported more anosmia (p<0.01), dysgeusia (p<0.01), difficulty concentrating (p=0.01), and irritability (p=0.01), and greater clinical and well-being severity scores (Flu-iiQ) than test-negative ILIs; they also had greater absenteeism (p<0.01) and lost income (median US$127.1, p<0.01). These results support the prioritization of Guatemalan farm workers for COVID-19 vaccination. |
